Search Results 71-80 of 17408 for ulcerative colitis

  1. Hyperbaric Oxygen Therapy for Ulcerative Colitis (HBOT-UC) - Mayo Clinic

    Hyperbaric Oxygen Therapy for Ulcerative Colitis (HBOT-UC) · Overview · Participation eligibility · Participating Mayo Clinic locations · More information ...

  2. A Study to Evaluate both the Efficacy and Safety Profile of CP-690,550 in Patients with Moderately to Severely Active Ulcerative Colitis - Mayo Clinic

    This study is designed to evaluate the efficacy and safety of tofacitinib (CP-690,550) in patients with moderate to severe ulcerative colitis who have failed or ...

  3. A Multicenter, Randomized, Double-Blind, Placebo-Controlled Induction Study to Evaluate the Efficacy and Safety of Upadacitinib (ABT-494) in Subjects With Moderately to Severely Active Ulcerative Colitis - Mayo Clinic

    ... Ulcerative Colitis. Print details. Share; Facebook · Twitter. Overview ... ulcerative colitis (UC). Participation eligibility. Participant eligibility ...

  4. Study for Participants With Ulcerative Colitis Previously Enrolled in Etrolizumab Phase II/III Studies - Mayo Clinic

    ... ulcerative colitis (UC) participants previously enrolled in etrolizumab Phase II/III studies. Participants with moderate to severe UC who were enrolled in ...

  5. The microbiome, fecal microbiota transplants and inflammatory bowel disease - Mayo Clinic

    Patients with IBD , either Crohn's disease (CD) or ulcerative colitis (UC), have a microbiome that is different from individuals in healthy populations ...

  6. Sharing Mayo Clinic: Lifting the weight of debilitating inflammatory bowel disease

    Ulcerative colitis and Crohn's disease are the two main types. Marissa began experiencing symptoms of inflammatory bowel disease when she was in her early ...

  7. Ulcerative colitis - Doctors and departments - Mayo Clinic

    This type of inflammatory bowel disease causes swelling and sores in the digestive tract. Learn more about symptoms and treatment.

  8. A Study to Assess Adverse Events and Change in Disease Activity From Intravenous (IV) and Subcutaneous (SC) Lutikizumab in Adult Participants With Active Ulcerative Colitis - Mayo Clinic

    ... Ulcerative Colitis. Print details. Share; Facebook · Twitter. Overview; Participation eligibility; Participating Mayo Clinic info; More information. Overview.

  9. Study to Evaluate the Safety and Efficacy of Two Drug Regimens in Subjects with Moderate to Severe Ulcerative Colitis - Mayo Clinic

    Study to Evaluate the Safety and Efficacy of Two Drug Regimens in Subjects with Moderate to Severe Ulcerative Colitis · More about research at Mayo Clinic · Mayo ...

  10. A Study of the Efficacy and Safety of Etrolizumab in Ulcerative Colitis Participants Who Are Refractory to or Intolerant of Tumor Necrosis Factor (TNF) Inhibitors - Mayo Clinic

    ... ulcerative colitis (UC) who are refractory to or intolerant of TNF inhibitors. Participation eligibility. Participant eligibility includes age, gender, type ...